BABA vs PPCB · P/E 20, rev $137.30B vs P/E 0.0, $3.9M cap
Alibaba Group Holding Ltd (BABA) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
PPCB does not have a complete income-statement cache yet.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the BABA and PPCB stock pages for the full models.
Not investment advice.